LUM and metabolic dysfunction-associated steatotic liver disease: Compared with NAFLD fibrosis stage 0–1 patients (n = 4), LUM, EFEMP1, FBN1, and THBS2 were remarkablely up-regulated in the fibrosis stage 3–4 state patients (n = 4) (Fig. 6a,b).